Journal
LANCET
Volume 356, Issue 9240, Pages 1493-1494Publisher
LANCET LTD
DOI: 10.1016/S0140-6736(00)02879-8
Keywords
-
Categories
Funding
- NCI NIH HHS [CA-75541, CA67372, CA21765] Funding Source: Medline
Ask authors/readers for more resources
Epstein-Barr virus (EBV) targeted therapeutic strategies for viral associated malignant diseases have received only perfunctory consideration, first, because latent herpesviruses have been intractable to antiviral chemotherapy and, second, because the role EBV has in maintenance of the malignant cell phenotype has been uncertain, Two patients with EBV related primary central nervous system lymphoma (PCNSL) in the setting of advanced AIDS, were treated with low dose hydroxyurea based on in vitro anti-EBV activity. The responses obtained here suggest the promise of antiviral approaches in select cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available